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Introduction
Several clathrin-independent mechanisms of endocytosis have 
been described and are the focus of much attention among cell 
biologists (Nichols and Lippincott-Schwartz, 2001; Johannes 
and Lamaze, 2002). Of particular interest is caveolar endo-
cytosis, a dynamin-dependent, cholesterol-sensitive uptake mecha-
nism (Mineo and Anderson, 2001; Pelkmans and Helenius, 
2002; Kirkham and Parton, 2005; Cheng et al., 2006a). Caveolar 
cargo varies with cell type and includes fl  uorophore-modifi  ed 
albumins, SV40 virus, cholera toxin B (CtxB) subunit, and 
fl  uorescent glycosphingolipid (GSL) analogues. Internalization 
of certain cell surface integrins also occurs via caveolae once 
the integrins are activated (e.g., by cross-linking; Upla et al., 
2004; Sharma et al., 2005). Regulation of caveolar endocytosis 
is only beginning to be understood; uptake by this mechanism 
is stimulated when cells are treated with phosphatase inhibitors 
(e.g., okadaic acid) or when certain caveolar cargo binds to its 
receptor (Parton et al., 1994; Tagawa et al., 2005). The stimula-
tion of caveolar endocytosis is accompanied by the increased 
activation of src and phosphorylation of caveolin-1 and dyna-
min, suggesting that stimulation occurs via increased kinase 
activities. Indeed, a recent screen of the human kinome identi-
fi  ed a total of 80 different kinases that are somehow involved 
in the uptake of SV40 virus, a caveolar marker (Pelkmans 
et al., 2005). We recently showed that caveolar uptake is also 
stimulated when cells are briefl  y incubated with either natural 
(e.g., bovine brain lactosylceramide [LacCer] or GM1 ganglio-
side) or synthetic (e.g., β-d-lactosyl-N-octanoyl-sphingosine) 
GSLs (Sharma et al., 2004; Kirkham et al., 2005). In each case, 
the sphingosine moiety was the natural D-erythro (D-e; also 
referred to as 2S,3R) stereoisomer. In this study, we tested a 
nonnatural stereoisomer of LacCer, β-d-lactosyl-N-octanoyl-l-
threo-sphingosine (L-t-LacCer or 2S,3S), and found unexpect-
edly that this analogue selectively inhibited the internalization 
of multiple caveolar markers, including the SV40 virus, rather 
than stimulating their uptake. We further show that this inhibi-
tion was caused by the disruption of plasma membrane (PM) 
microdomains enriched in GSLs and cholesterol and by an inhi-
bition of integrin activation and signaling.
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aveolar endocytosis is an important mechanism 
for the uptake of certain pathogens and toxins 
and also plays a role in the internalization of some 
plasma membrane (PM) lipids and proteins. However, 
the regulation of caveolar endocytosis is not well un-
derstood. We previously demonstrated that caveolar 
endocytosis and β1-integrin signaling are stimulated by 
exogenous glycosphingolipids (GSLs). In this study, we 
show that a synthetic GSL with nonnatural   stereochemistry, 
β-D-lactosyl-N-octanoyl-L-threo-sphingosine, (1) s electively 
inhibits caveolar endocytosis and SV40 virus   infection, 
(2) blocks the clustering of lipids and proteins into GSLs 
and cholesterol-enriched microdomains (rafts) at the PM, 
and (3) inhibits β1-integrin activation and downstream 
signaling. Finally, we show that small interfering RNA 
knockdown of β1 integrin in human skin ﬁ  broblasts blocks 
caveolar endocytosis and the stimulation of signaling by a 
GSL with natural stereochemistry. These experiments iden-
tify a new compound that can interfere with biological 
processes by inhibiting microdomain formation and also 
identify β1 integrin as a potential mediator of signaling 
by GSLs.
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Results and discussion
To examine the effect of LacCer stereoisomers on mechanisms 
of endocytosis in human skin fi   broblasts (HSFs), various 
fl  uorescent endocytic markers were used. These probes were   
previously characterized as relatively specifi  c markers of up-
take via caveolae- (anti–β1-integrin [β1-Fab] and fl  uorescent 
albumin), clathrin- (transferrin [Tfn]), and RhoA (interleukin-2 
receptor β subunit [IL-2R])-regulated mechanisms using 
dominant- negative  proteins and biochemical inhibitors (Lamaze 
et al., 2001; Sabharanjak et al., 2002; Sharma et al., 2004, 
2005; Cheng et al., 2006b). We used 1 mg/ml of fl  uorescent 
dextran as a probe for Cdc42-regulated endocytosis, as this con-
centration of dextran has been shown to selectively label endo-
somes derived from this pathway (Sabharanjak et al., 2002; 
Cheng et al., 2006b). An Fab fragment of an antibody (Ab) 
against GFP was used to follow the endocytosis of glycosyl-
  phosphatidylinositol (GPI)–GFP via this pathway. Endocytosis 
of GPI-GFP was   perturbed by the expression of dominant-
negative Cdc42 (Fig. S1 A, available at http://www.jcb.org/
cgi/content/full/jcb.200609149/DC1). In addition, endocytosed 
GPI-GFP closely colocalized with endocytosed dextran (Fig. 
S1 B). These results indicate that dextran and GPI-GFP are 
  internalized via the Cdc42-regulated pathway in HSFs as they 
are in CHO cells (Sabharanjak et al., 2002).
Cells were coincubated with the endocytic probes and 
5 μM L-t-LacCer or the corresponding natural (D-e) stereoisomer 
for 30 min at 10°C (see Materials and methods).   Biochemical 
analysis indicated that approximately equal amounts of either 
LacCer stereoisomer became cell associated under these 
  incubation conditions ( 3 pmol/10
6 cells). The samples were 
then briefl  y warmed to 37°C to allow endocytosis to occur, and 
the amount of internalization was quantifi  ed by image analysis. 
P  retreatment of cells with l-t-LacCer inhibited the uptake 
of caveolar markers (labeled albumin or anti–β1- integrin 
Fab   fragment) by  70% relative to untreated control cells, 
whereas there was a slight stimulation ( 10–20%) of Cdc42-
regulated (dextran and GPI-GFP) and RhoA-regulated (IL-2R) 
endocytosis; little effect was seen on the clathrin-dependent 
  internalization of Tfn (Fig. 1, A and B). In contrast, when 
β-d-lactosyl-N-octanoyl-d-erythro-sphingosine (D-e-LacCer) 
was used, internalization via caveolae was increased 60–100% 
relative to untreated controls as previously reported (Sharma 
et al., 2004). Quantitative analysis of surface caveolae by elec-
tron microscopy (Sharma et al., 2004) after treatment of cells with 
the LacCer stereoisomers showed that the l-t isomer increased 
the num  ber of caveolae present at the PM, which is consistent 
with the inhibition of internalization by this route, whereas 
the D-e isomer reduced the number of surface-connected 
caveolae, presumably refl  ecting an increase in internalization of 
Figure 1.  L-t-LacCer inhibits caveolar endo-
cytosis and SV40 infection. (A and B) HSFs were 
incubated ± LacCer stereoisomers for 30 min 
at 10°C, and endocytosis of various markers 
after 5 min at 37°C was observed (see Materials 
and methods). Endocytosis was quantiﬁ  ed by 
image analysis (n ≥ 30 cells/marker) and 
  expressed as a percentage of controls without 
lipid addition. Note that L-t-LacCer inhibited 
the uptake of caveolar markers (anti–β1-i  ntegrin 
Fab and albumin) but not markers for other 
  endocytic mechanisms. Dotted lines in B out-
line two cells in the ﬁ  eld. (C) HSFs were incu-
bated ± LacCer stereoisomers as in A, warmed 
for 30 s at 37°C, processed for EM, and the 
number of surface-connected caveolae was 
determined (n ≥ 15 cells/condition; Sharma 
et al., 2004). (D and E) CV1 cells were incu-
bated  ± LacCer stereoisomers as in A and 
were coincubated for 1 h at 10°C with SV40 
virus (MOI = 15). Samples were washed, in-
cubated for 14 h, and stained for the large T 
antigen (Tsai et al., 2003). Values in E are 
means ± SD (error bars; n ≥ 50 cells/condi-
tion; three independent experiments). (F and G) 
CV1 cells were treated with SV40 for 1 h as in 
D and E, and SV40 binding to live cells was 
detected using anti-SV40 VP1 mAb (Chen and 
Norkin, 1999). Values in G are means ± SD 
(n ≥ 20 cells from two independent experi-
ments). Bars, 10 μm.GLYCOLIPID INHIBITION OF MEMBRANE DOMAINS • SINGH ET AL. 897
caveolae-  derived vesicles (Fig. 1 C; Sharma et al., 2004). The 
results in Fig. 1 show that pretreatment of cells with the non-
natural LacCer stereoisomer blocks caveolar endocytosis while 
not markedly affecting other mechanisms of internalization.
The effect of L-t-LacCer treatment on SV40 infection in 
monkey CV1 cells was examined next because endocytosis of   
this virus has been extensively characterized in this cell type 
and is shown to occur via caveolae (Anderson et al., 1996; Stang 
et al., 1997; Pelkmans et al., 2001). Pretreatment of cells with 
L-t-LacCer dramatically reduced viral infection as monitored 
by the expression of the large T antigen after 14 h at 37°C, 
whereas D-e-LacCer had no effect relative to untreated control 
samples (Fig. 1, D and E). Because the inhibition of SV40 
  infection by L-t-LacCer could result from effects on virus bind-
ing as well as endocytosis, we also studied the effect of L-t-Lac-
Cer on SV40 binding. We found that the L-t-LacCer treatment 
inhibited SV40 binding by  80% (Fig. 1, F and G), as detected 
using a mAb to the SV40 major capsid protein VP1 (Chen and 
Norkin, 1999). Thus, the effect of the nonnatural LacCer isomer 
on SV40 infection was probably mainly caused by its inhibition 
of SV40 binding to the cell surface.
We next addressed potential mechanisms by which L-t-
LacCer might selectively inhibit caveolar endocytosis as well as 
the binding of SV40 to the cell surface. One possibility is that 
L-t-LacCer might disrupt PM microdomains, which are local 
regions of the PM enriched in GSLs and cholesterol that may 
act as organizing centers for particular proteins (for reviews see 
London and Brown, 2000; Rajendran and Simons, 2005). To 
test this possibility, cells were incubated with AlexaFluor594-
CtxB at 10°C to label GM1 ganglioside at the PM followed by 
an anti-CtxB IgG. This treatment caused the formation of nu-
merous micrometer-size clusters of CtxB at the PM, which were 
not present in the absence of anti-CtxB IgG (Fig. 2 A, left vs. 
middle). Importantly, when cells were pretreated with L-t-Lac-
Cer for 30 min at 10°C before incubation with the labeled CtxB 
and cross-linking anti-CtxB IgG, clustering into PM domains 
was prevented (Fig. 2 A, right). No inhibition of domain forma-
tion was observed using D-e-LacCer; rather, the D-e isomer 
  induced the formation of large domains enriched in GM1 ganglio-
side and cholesterol in the absence of the cross-linking IgG 
(Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200609149/DC1; Sharma et al., 2005).
We then incubated CV1 cells at low temperature with 
SV40 virus and found that this treatment induced the formation 
of PM domains enriched in GM1 ganglioside and cholesterol 
(Fig. 2, B and C; left vs. middle), which is remarkably similar to 
the clustered microdomains induced by CtxB cross-linking 
(Fig. 2 A). Interestingly, the pretreatment of CV1 cells with L-t-
LacCer prevented the SV40 induction of these PM domains 
(Fig. 2, B and C; right). These results provide a potential expla-
nation for the reduction in SV40 binding to CV1 cells because 
GM1 ganglioside is a receptor for SV40 (Tsai et al., 2003), and 
clustering of GM1 may be required for maximal SV40 binding.
Together, these experiments demonstrate that the induc-
tion of PM domains by various treatments (cross-linking Abs or 
SV40) is prevented by L-t-LacCer. This modulation of PM 
  domain organization may disrupt the distribution of potential 
cargo in microdomains and, thus, inhibit their endocytosis via 
caveolae. The concept that microdomain clustering is important 
for caveolar endocytosis is supported by previous observations. 
First, unlike BODIPY–D-e-LacCer, which associates with micro-
domains and is internalized via caveolae, the L-t isomer of 
BODIPY-LacCer does not partition into microdomains at the 
PM and is not selectively endocytosed via caveolae (Singh 
et al., 2006). Second, agents that stimulate the clustering of 
GSL-enriched microdomains at the PM (e.g., exogenous GSLs 
and β1-integrin cross-linking Abs) also stimulate caveolar 
endocytosis (Sharma et al., 2004, 2005).
A second mechanism by which L-t-LacCer might inhibit 
caveolar internalization is by disrupting transmembrane signal-
ing events required for endocytosis. We focused on signaling 
through β1 integrin because this integrin is internalized via 
  caveolae in HSFs and other cell types (Upla et al., 2004; Sharma 
et al., 2005) and because an early event after integrin activation 
is signaling through src, a kinase whose activity is required 
for caveolar endocytosis (Mineo and Anderson, 2001; Arias-
S  algado et al., 2003; Sharma et al., 2005). We fi  rst examined the 
activation of β1 integrin in HSFs after cross-linking with a 
stimulatory β1-integrin Ab (β1-stim Ab) using the HUTS-4 Ab, 
which only binds to β1 integrins in their activated conformation 
(Luque et al., 1996). Treatment with the stimulatory Ab dramat-
ically increased HUTS binding (Fig. 3, A and B), whereas 
Figure 2.  L-t-LacCer inhibits the formation of PM domains. (A–C) PM do-
mains enriched in GM1 ganglioside (A and B) or cholesterol (C) were visu-
alized using ﬂ   uorescent CtxB or BC-Θ, respectively (see Materials and 
methods). Clustering of these probes was induced using an anti-CtxB Ab or 
SV40 virus. Note the inhibition of microdomain clustering when cells were 
pretreated with L-t-LacCer compared with untreated control samples. A, 
HSFs; B and C, CV1 cells. Bars, 10 μm.JCB • VOLUME 176 • NUMBER 7 • 2007  898
  pretreatment with L-t-LacCer before incubation with β1-stim 
Ab reduced HUTS-4 binding to levels seen in untreated control 
cells. In contrast, when D-e-LacCer  was used, the Ab-induced 
activation of β1 integrin was not inhibited. When L-t-LacCer 
was incubated with HSFs in the absence of β1-stim Ab, no 
i  ncrease in HUTS binding was seen (Fig. S3, A and B; available 
at http://www.jcb.org/cgi/content/full/jcb.200609149/DC1). 
This is in contrast to D-e-LacCer, which activated β1 integrin in 
the absence of the β1-stim Ab to a similar extent as when the 
Ab was used alone (Fig. S3, A and B; Sharma et al., 2005).
Because β1 integrins have been shown to activate src 
  kinases and src phosphorylation is required for caveolar endo-
cytosis (Arias-Salgado et al., 2003; Sharma et al., 2004), we also 
examined the effect of L-t-LacCer treatments on this process. 
Cells were incubated for 30 min at 10°C ± the LacCer stereo-
isomers and/or the β1-stim Ab followed by a 30-s incubation at 
37°C. Cell lysates were then immunoblotted for src and phos-
pho-(Y416) src. Src kinase was activated (phosphorylated at 
Y416) by treatment with D-e-LacCer to a level similar to that 
seen with the stimulating Ab, and this activation could be 
blocked by the src inhibitor PP2 (Fig. 3 C). In contrast, little or 
no src activation was observed upon treatment with L-t-LacCer. 
Furthermore, pretreatment of cells with L-t-LacCer inhibited 
src phosphorylation induced by the β1-stim Ab, whereas pre-
treatment with D-e-LacCer did not substantially affect src phos-
phorylation in response to β1-stim Ab (Fig. 3 C).
Several features of our studies suggest that the LacCer ste-
reoisomers may regulate caveolar endocytosis via modulation 
of β1-integrin signaling. First, both D-e-LacCer and β1 integrin 
stimulate src activation and caveolar endocytosis to a similar 
degree (Fig. 3; Sharma et al., 2004, 2005). Second, treatment 
with L-t-LacCer inhibits β1 integrin–mediated src signaling as 
well as caveolar endocytosis (Figs. 1 A and 3 C). To further 
e  xamine the role of β1 integrin in the regulation of caveolar 
  endocytosis in HSFs, we used an siRNA approach to deplete this 
integrin and studied the uptake of various markers. We fi  rst vali-
dated the use of three different β1-integrin siRNAs and found 
that these reduced β1-integrin levels in HeLa cells  80% rela-
tive to untreated cells (Fig. S3 C). We then used electroporation 
to transfect HSFs with a β1-integrin siRNA and found that the 
levels of β1 integrin were reduced by  75% in the transfected 
cells as assessed by immunofl  uorescence (Fig. S3 D).
We then examined the effect of β1-integrin knockdown 
on the uptake of multiple endocytic markers. Endocytosis of the 
caveolar markers albumin and BODIPY-LacCer was dramati-
cally reduced in cells transfected with β1-integrin siRNA rela-
tive to that in nontransfected cells. In contrast, no effect of 
β1-integrin siRNA treatment was seen on clathrin (Tfn), Cdc42 
(dextran and GPI-GFP), or RhoA (IL-2R) internalization (Fig. 
4, A and B). Control experiments showed that clathrin heavy 
chain siRNA treatment resulted in a strong inhibition of Tfn 
  uptake but had little effect on albumin or BODIPY-LacCer 
 internalization (Fig. 4 B). Finally, we examined the effect of 
β1-integrin knockdown on src phosphorylation in HSFs treated 
with the LacCer stereoisomers using immunofl  uorescence. 
  Although the phosphorylation of src was increased in D-e-LacCer–
treated cells (Fig. 3 C), this stimulation was reduced by 65–
75% in individual cells in which β1 integrin had been depleted 
(Fig. 4 C). As expected, no further reduction of phospho-src 
was observed in cells treated with L-t-LacCer and depleted of 
β1 integrin (not depicted) because src phosphorylation was in-
hibited by the L-t stereoisomer (Fig. 3 C).
The inhibition of caveolar endocytosis by β1-integrin 
knockdown in HSFs suggests a key role for β1 integrin in the 
regulation of this endocytic process by GSLs. For example, natu-
ral GSLs such as D-e-LacCer that stimulate caveolar endocytosis 
Figure 3.  Activation of 𝗃1 integrin and stimulation of 
src kinase is inhibited by L-t-LacCer. (A and B) HSFs 
were serum starved for 2–3 h and were either 
  untreated (control) or incubated with a stimulating β1-
integrin IgG (β1-stim) or with the indicated LacCer iso-
mers for 30 min at 10°C. For treatments with the 
LacCer isomers, samples were further incubated with 
β1-stim Ab and the indicated LacCer for 30 min at 
10°C. All samples were then warmed for 30 s at 
37°C, ﬁ  xed, and stained with HUTS-4 Ab that recog-
nizes β1 integrin in its active conformation (Luque 
et al., 1996). Note the absence of β1-integrin activa-
tion in cells pretreated with L-t-LacCer. Quantitation in 
B was performed by image analysis (n ≥ 10 cells/
condition; three independent experiments). Error bars 
represent SD. Bar, 10 μm. (C) HSFs were treated with 
D-e-LacCer (±PP2), L-t-LacCer, PDGF, or with β1 stim 
Ab ± LacCer isomers (see Materials and methods). 
Samples were warmed for 30 s at 37°C, lysed, and 
the cell lysates were blotted for src and phospho-
Src (Y416).GLYCOLIPID INHIBITION OF MEMBRANE DOMAINS • SINGH ET AL. 899
may do so by increasing β1-integrin clustering, whereas L-t-
LacCer may inhibit endocytosis via caveolae by preventing this 
clustering. Further studies are needed to determine (1) the 
  applicability of our fi  ndings to other cell types, (2) the role of 
other integrin components (e.g., various αβ heterodimers) in 
modulating caveolar uptake, and (3) whether the regulation of 
caveolar endocytosis is restricted to integrins that are internal-
ized via caveolae or also includes integrins that are endocytosed 
via the clathrin pathway (e.g., αVβ5; Memmo and McKeown-
Longo, 1998).
Our data support a general model in which exogenously 
supplied D-e-LacCer or other sphingolipids with the natural 
D-e stereochemistry promote the coalescence of PM micro-
domains, leading to the clustering and activation of transmembrane 
proteins that can initiate a signaling cascade required for caveo-
lar endocytosis. In HSFs, β1 integrin appears to be a key mole-
cule involved in transducing this signal across the PM bilayer; 
however, other signaling proteins that partition into lipid micro-
domains may be similarly affected by exogenous lipids in HSFs 
or other cell types. Our results also suggest a potential mecha-
nism whereby certain tumor cells that shed gangliosides can 
  alter the properties of nearby cells (Birkle et al., 2003; Guerrera 
and Ladisch, 2003). Most importantly, the results of the current 
study document a dominant-negative lipid, L-t-LacCer, which 
selectively inhibits caveolar endocytosis of multiple markers 
by interfering with microdomain clustering and β1-integrin 
  signaling. Of additional interest is our finding that the non-
natural stereoisomer of LacCer dramatically inhibited SV40 infec-
tion, most likely by disrupting PM domains that are required for 
optimal binding of the virus to the cell surface. Finally, we sug-
gest that the disruption of membrane microdomains by L-t-Lac-
Cer may represent a new approach for the treatment of certain 
diseases and infectious agents that use lipid rafts or raft proteins 
as targets (Simons and Ehehalt, 2002).
Materials and methods
Cell culture
Normal HSFs (Coriell Institute for Medical Research), HeLa, and CV1 cells 
(American Type Culture Collection) were used as described previously 
(Pelkmans et al., 2001; Singh et al., 2003). The SV40 construct (pUC-
SVH388-2) was obtained from the American Type Culture Collection, 
transfected into CV1 cells, and the virus was harvested after maximum 
c  ytopathic effect. The virus was titered and used at an MOI of 15.
Lipids, ﬂ  uorescent probes, and miscellaneous reagents
D-e-LacCer was purchased from Avanti Polar Lipids, Inc., and L-t-LacCer 
was synthesized by N. Gretskaya (Shemyakin Institute, Moscow, Russia). 
LacCer isomers were complexed to defatted BSA and incubated with cells 
at a ﬁ  nal concentration of 5 μM (Sharma et al., 2005). Fluorescent Alexa-
Fluor594- and -647–labeled CtxB, Tfn, dextran (10 kD), Ab labeling kits, 
and ﬂ  uorescent secondary Abs were obtained from Invitrogen. An anti–β1 
integrin (IgG1) from BD Biosciences was used as a stimulatory Ab (β1-stim 
Ab) and for the preparation of an Fab fragment using a kit from Pierce 
Chemical Co. Abs were ﬂ  uorescently labeled with an AlexaFluor dye as 
described previously (Sharma et al., 2005). An AlexaFluor594-Fab frag-
ment against GFP was prepared similarly from an anti-GFP Ab (Invitro-
gen). The HUTS-4 β1-integrin Ab was purchased from Chemicon. A 
phycoerythrin-labeled IL-2R Ab was obtained from BD Biosciences. Src 
and phospho-Src Abs for Western blotting were obtained from Cell Signal-
ing Technology. Antiphospho-src (Y416) mAb for immunoﬂ   uorescence 
studies was purchased from Upstate Biotechnology. CtxB, large T antigen 
Abs, and tyrosine kinase inhibitor (PP2) were purchased from Calbiochem. 
The biotinylated derivative (BC-Θ) of perfringolysin O (Θ toxin) was ob-
tained from Y. Ohno-Iwashita (Tokyo Metropolitan Institute, Tokyo, Japan) 
and used as described previously (Waheed et al., 2001) using Alexa-
Fluor594-streptavidin (Invitrogen) to visualize its distribution on the cell 
s  urface. A mAb (pab597) against SV40 VP1 was provided by L. Norkin 
(University of Massachusetts, Amherst, MA) and used as described previ-
ously (Chen and Norkin, 1999). All other reagents were purchased from 
Sigma-Aldrich.
Constructs, transfections, and knockdown experiments
DNA constructs encoding GPI-GFP, dominant-negative Cdc42, and IL-2R 
were gifts from J. Lippincott-Schwartz (National Institutes of Health, 
Bethesda, MD), D. Billadeau (Mayo Foundation, Rochester, MN) and A. 
Dautry-Varsat (Institute Pasteur, Paris, France), respectively. pDsRed2-nuc 
and pECFP-nuc were purchased from CLONTECH Laboratories, Inc. Trans-
fection of DNA constructs was performed using a Nucleofector II apparatus 
(Amaxa Biosystems).
siRNAs for β1 integrin (Stealth Select RNAi; oligonucleotide IDs 
HSS105559, HSS105560, and HSS105561) and clathrin heavy chain 
Figure 4.  Knockdown of 𝗃1 integrin inhibits caveolar endocytosis and 
phosphorylation of src in HSFs. (A and B) Cells were cotransfected with 
β1-integrin siRNA (±nuclear reporter; see Materials and methods). After 
48 h, cells were incubated with BODIPY-LacCer, ﬂ  uorescent albumin, Tfn, 
dextran, anti–IL-2R, or anti–GFP-Fab (see Materials and methods), and 
  endocytosis was examined after 3 min at 37°C. (A) Note the inhibition of 
BODIPY-LacCer (but not Tfn or dextran) internalization. (B) Results were 
quantiﬁ  ed by image analysis. Additional experiments using a siRNA for 
the clathrin heavy chain (CHC) demonstrated the inhibition of Tfn uptake, 
with no effect on albumin or BODIPY-LacCer internalization. (C and D) β1 
integrin was depleted in HSFs by transfection as in A. The cells were then 
incubated with D-e-LacCer for 30 min at 10°C, washed, and warmed for 
30 s at 37°C. Immunoﬂ  uorescence was performed using anti-pSrc (Y416) 
mAb and was quantiﬁ  ed by image analysis relative to adjacent nontrans-
fected cells (n ≥ 10 cells per condition in two independent experiments; D). 
Note the inhibition of p-Src staining in cells showing nuclear reporter 
  ﬂ  uorescence. Error bars represent SD. Bars, 10 μm.JCB • VOLUME 176 • NUMBER 7 • 2007  900
(ON-TARGETplus SMARTpool L-004001-00-0010) were purchased from 
Invitrogen and Dharmacon, respectively. Knockdown in HeLa cells was 
performed using LipofectAMINE 2000 (Invitrogen). For knockdown in 
HSFs, cells were cotransfected with the siRNA of interest and pDsRed2-
Nuc (experiments using BODIPY-LacCer, albumin, or dextran), pECFP-Nuc 
(experiments using AlexaFluor594-Tfn), or no reporter (experiments using 
GPI-GFP or IL-2R) using the Nucleofector II apparatus. Transfections were 
performed using 360 pmol siRNA and 1 μg of reporter DNA. Experiments 
were performed 48 h after transfection.
Endocytosis assays
For endocytosis of BODIPY-LacCer or AlexaFluor-labeled anti–β1-integrin 
Fab or Tfn, HSFs were preincubated with the ﬂ  uorescent marker for 30 min 
at 10°C, washed, and further incubated for 3 or 5 min at 37°C. For Alexa-
Fluor-labeled albumin and dextran, cells were incubated for 3 or 5 min at 
37°C without preincubation. Endocytosis of IL-2R was performed as 
  described previously (Cheng et al., 2006b). For GPI-anchored protein up-
take, HSFs were ﬁ  rst transfected with GPI-GFP for 48 h and then were 
incubated with AlexaFluor594-labeled anti–GFP-Fab for 30 min at 10°C, 
washed, and incubated for 5 min at 37°C. All samples were then either 
acid stripped or back exchanged to remove cell surface ﬂ  uorescence 
  before ﬂ  uorescence microscopy (Singh et al., 2003).
PM binding of SV40 virus
CV1 cells were incubated ± LacCer stereoisomers for 30 min at 10°C and 
coincubated for 1 h at 10°C with SV40 virus (MOI = 15). Samples were 
then washed and stained for SV40 binding at the PM using anti-SV40 VP1 
mAb for 30 min at 10°C . Cells were washed, incubated with Alexa-
Fluor594-labeled anti–mouse secondary Ab, and observed by ﬂ  uores-
cence microscopy at 10°C.
Visualization of PM microdomains
For the visualization of GM1 ganglioside microdomains at the PM, HSFs 
and CV1 cells were incubated for 30 min at 10°C ± L-t-LacCer and further 
incubated (for 30 min at 10°C) with ﬂ   uorescent CtxB. Samples were 
washed and incubated with anti-CtxB IgG (30 min for HSFs) or SV40 virus 
(1 h for CV1 cells) at 10°C. Cells were then washed and observed under 
the ﬂ  uorescence microscope (IX70; Olympus) at 10°C. For the visualiza-
tion of cholesterol microdomains, CV1 cells were incubated (for 30 min 
at 10°C) ± L-t-LacCer followed by SV40 virus for 1 h at 10°C. Cells 
were then washed and incubated with biotinylated BC-Θ followed by 
AlexaFluor594-streptavidin.
Src phosphorylation
HSFs were serum starved for 2–3 h and treated with D-e-LacCer, L-t-LacCer, 
or 50 μg/ml PDGF for 30 min at 10°C in HBSS. In one experiment, cells 
were pretreated with 15 μM PP2 for 30 min at 37°C before incubation 
with D-e-LacCer. In another experiment, cells were either untreated or 
treated with the LacCer isomers for 30 min at 10°C followed by incubation 
with β1-stim Ab for 30 min at 10°C. All samples were then washed and 
warmed for 30 s at 37°C before cell lysis. Lysates were then immunoblotted 
for Src and phospho-Src (Y416).
Miscellaneous methods
Fluorescence microscopy was performed using a ﬂ  uorescence microscope   
(IX70; Olympus) equipped with 60× 1.4 NA and 100× 1.35 NA objec-
tives and a CCD camera (C4742; Hamamatsu). For quantitative studies, 
all photomicrographs in a given experiment were exposed and processed 
identically for a given ﬂ   uorophore and were analyzed using the Meta-
Morph image processing program (version 6.2; Universal Imaging Corp.). 
Quantitative results are expressed as means ± SDs. Images were prepared 
for individual ﬁ  gures using Photoshop CS (Adobe).
Online supplemental material
Fig. S1 shows the characterization of endocytosis of GPI-GFP via the Cdc-
42–regulated pathway in HSFs. Fig. S2 illustrates microdomains contain-
ing cholesterol, GM1 ganglioside, and β1 integrin in HSFs treated with 
D-e-LacCer versus L-t-LacCer. Fig. S3 shows the effects of D-e- and L-t-LacCer 
on β1-integrin activation and the characterization of β1-integrin knock-
down in HeLa cells and HSFs. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200609149/DC1.
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